journal article·2024-07-03

A Bioswitchable MiRNA Delivery System: Tetrahedral Framework DNA-Based miRNA Delivery System for Applications in Wound Healing

Xiaoying Lyu, Haoyan Wu, Mengzhuo Xu, Ye Chen, Zhiqiang Liu, Mei Zhang, Taoran Tian, Yunfeng Lin, Songhang Li, Xiaoxiao Cai

ACS Applied Materials & Interfaces· Volume 16· Issue 26
Publisher page

Abstract

The human body's primary line of defense, the skin, is especially prone to harm. Although microRNA (miRNA)-based therapies have attracted increasing attention for skin wound healing, their applications remain limited owing to a range of issues. Tetrahedral framework DNA (tFNA), a nanomaterial possessing nucleic acid characteristics, exhibits an excellent biocompatibility, in addition to anti-inflammatory and transdermal delivery capabilities, and can accelerate skin wound healing. Due to its potential to exert synergistic action with therapeutic miRNA, tFNA has been considered an ideal vehicle for miRNA therapy. The design and synthesis of a bioswitchable miRNA delivery system (BiRDS) is reported, which contains three miRNAs as well as a nucleic acid core to maximize the loading capacity while preserving the characteristics of tFNA. A high stability, excellent permeability of cells as well as tissues and good biological compatibility are demonstrated. By selectively inhibiting heparin-binding epidermal growth factor (HB-EGF), the BiRDS can inhibit the NF-κB pathway while simultaneously controlling the PTEN/Akt pathway. As a result, the BiRDS helps wound healing go through the inflammation to the proliferative phase. This study demonstrates the advantages of the BiRDS in miRNA-based therapy and provides new research ideas for the treatment of skin-related diseases.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: RNA Interference and Gene Delivery · Advanced biosensing and bioanalysis techniques · Silk-based biomaterials and applications

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

State Key Laboratory of Oral Diseases, National Center for Stomatology, National Clinical Research Center for Oral Diseases, West China Hospital of Stomatology, Sichuan University, Chengdu, Sichuan 610041, China

Sichuan Provincial Engineering Research Center of Oral Biomaterials, Chengdu, Sichuan 610041, China

National Center for Translational Medicine, Shanghai Jiao Tong University, Shanghai 200240, China

Funding

West China School of Stomatology, Sichuan University · China Postdoctoral Science Foundation · Sichuan Province Youth Science and Technology Innovation Team · National Natural Science Foundation of China · Sichuan Province Science and Technology Support Program · Miaozi Project in Science and Technology Innovation Program of Sichuan Province

References (56)

Show source-provided references
1. 10.1002/adma.20210017610.1002/adma.202100176 ↗
2. 10.1016/j.omtn.2017.06.00310.1016/j.omtn.2017.06.003 ↗
3. 10.1056/NEJM19990902341100610.1056/NEJM199909023411006 ↗
4. 10.1159/00033961310.1159/000339613 ↗
5. 10.1038/nature0724210.1038/nature07242 ↗
6. 10.1038/gt.2011.5010.1038/gt.2011.50 ↗
7. 10.1002/btm2.1034310.1002/btm2.10343 ↗
8. 10.1186/s12951-023-01778-610.1186/s12951-023-01778-6 ↗
9. 10.1172/JCI7905210.1172/JCI79052 ↗
10. 10.1016/j.jid.2017.08.00310.1016/j.jid.2017.08.003 ↗
11. 10.1186/s12877-021-02046-810.1186/s12877-021-02046-8 ↗
12. 10.1016/j.cell.2009.01.00210.1016/j.cell.2009.01.002 ↗
13. 10.1016/j.cell.2018.03.00610.1016/j.cell.2018.03.006 ↗
14. 10.1016/j.jconrel.2019.10.00710.1016/j.jconrel.2019.10.007 ↗
15. 10.1038/s41576-021-00439-410.1038/s41576-021-00439-4 ↗
16. 10.1038/nrd.2016.24610.1038/nrd.2016.246 ↗
17. 10.1038/nbt.150410.1038/nbt.1504 ↗
18. 10.1007/s13346-022-01138-110.1007/s13346-022-01138-1 ↗
19. 10.1016/j.jconrel.2015.12.01210.1016/j.jconrel.2015.12.012 ↗
20. 10.1016/j.addr.2021.11383410.1016/j.addr.2021.113834 ↗
21. 10.1038/s41565-021-00898-010.1038/s41565-021-00898-0 ↗
22. 10.1016/j.jconrel.2020.03.04010.1016/j.jconrel.2020.03.040 ↗
23. 10.1002/adma.20190108110.1002/adma.201901081 ↗
24. 10.1021/acsami.2c2257910.1021/acsami.2c22579 ↗
25. 10.1038/s41596-020-0355-z10.1038/s41596-020-0355-z ↗
26. 10.1002/adma.20227031610.1002/adma.202270316 ↗
27. 10.1002/advs.20220205810.1002/advs.202202058 ↗
28. 10.1016/j.bioactmat.2021.11.03110.1016/j.bioactmat.2021.11.031 ↗
29. 10.1021/acsnano.3c0210210.1021/acsnano.3c02102 ↗
30. 10.1002/smll.20230232610.1002/smll.202302326 ↗
31. 10.1038/s41392-024-01736-010.1038/s41392-024-01736-0 ↗
32. 10.1002/advs.20230870110.1002/advs.202308701 ↗
33. 10.1038/s41413-024-00319-710.1038/s41413-024-00319-7 ↗
34. 10.1038/s41413-022-00212-110.1038/s41413-022-00212-1 ↗
35. 10.1038/s41596-022-00791-710.1038/s41596-022-00791-7 ↗
36. 10.1002/adma.20210782010.1002/adma.202107820 ↗
37. 10.1002/advs.20230370610.1002/advs.202303706 ↗
38. 10.1038/s41467-019-09029-910.1038/s41467-019-09029-9 ↗
39. 10.1111/cpr.1349510.1111/cpr.13495 ↗
40. 10.1111/cpr.1270810.1111/cpr.12708 ↗
41. 10.1038/s41392-020-0173-310.1038/s41392-020-0173-3 ↗
42. 10.1002/advs.20230662210.1002/advs.202306622 ↗
43. 10.1021/acs.nanolett.1c0500310.1021/acs.nanolett.1c05003 ↗
44. 10.1111/cpr.1327910.1111/cpr.13279 ↗
45. 10.1038/s41368-024-00290-310.1038/s41368-024-00290-3 ↗
46. 10.1002/smll.20210435910.1002/smll.202104359 ↗
47. 10.1002/adma.20220428710.1002/adma.202204287 ↗
48. 10.7150/thno.430810.7150/thno.4308 ↗
49. 10.1126/science.aam889710.1126/science.aam8897 ↗
50. 10.1111/cpr.1349510.1111/cpr.13495 ↗
51. 10.1038/jid.2012.7810.1038/jid.2012.78 ↗
52. 10.1007/s13577-021-00544-w10.1007/s13577-021-00544-w ↗
53. 10.1016/j.ejphar.2016.10.01510.1016/j.ejphar.2016.10.015 ↗
54. 10.1098/rsob.21012010.1098/rsob.210120 ↗
55. 10.1002/(SICI)1097-4652(200003)182:3<311::AID-JCP1>3.0.CO;2-910.1002/(SICI)1097-4652(200003)182:3<311::AID-JCP1>3.0.CO;2-9 ↗
56. 10.1007/s00412-018-0659-810.1007/s00412-018-0659-8 ↗